Combination treatments for chemokinemediated diseases

Details for Australian Patent Application No. 2003220384 (hide)

Owner Schering Corporation

Inventors Bober, Loretta A; Taveras, Arthur G; Lundell, Daniel; Fine, Jay S; Biju, Purakkattle; Chao, Jianhua; Kreutner, William; Billah, Motasim; Jakway, James; Yu, Younong

Agent Griffith Hack

Pub. Number AU-B-2003220384

PCT Number PCT/US03/08287

PCT Pub. Number WO2003/080053

Priority 60/365,314 18.03.02 US

Filing date 17 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 10 May 2007

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/277 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

A61K 31/443 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/365,314 18.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003220384

10 May 2007 Application Accepted

  Published as AU-B-2003220384

6 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003220385-A hearing aid device, components thereof and related production process

2003220383-CONTROLLING TIMING OF MAIL PIECES BEING PROCESSED BY A MAILING SYSTEM